{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-051573","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.691742+00:00","generated_at":"2026-05-19T22:28:57.046264+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Onconetix shareholders approve reverse stock split ratio range 1:10 to 1:150","bullets":["Reverse stock split proposal approved: 11,956,279 For, 4,222,940 Against, 153,929 Abstentions.","Board authorized to select exact ratio (1-for-10 to 1-for-150) anytime within one year of May 30, 2025.","Adjournment proposal also approved: 13,570,278 For, 2,367,590 Against, 395,280 Abstentions.","44,358,422 shares of common stock were outstanding as of the April 14, 2025 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-051573","json":"https://secwatch.observer/filing/0001213900-25-051573.json","markdown":"https://secwatch.observer/filing/0001213900-25-051573.md","text":"https://secwatch.observer/filing/0001213900-25-051573.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025051573/0001213900-25-051573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390025051573/ea0244883-8k_onconetix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T22:28:57.046264+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}